These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 3811292)

  • 1. [Effect of the modification of low density lipoproteins by thrombin on their interaction with fibronectin].
    Chulkova TM
    Vopr Med Khim; 1986; 32(6):70-3. PubMed ID: 3811292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Interaction of enzymatically modified low-density lipoproteins with fibronectin].
    Chulkova TM
    Biull Eksp Biol Med; 1985 Sep; 100(9):301-3. PubMed ID: 3929855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Study of the interaction of low-density lipoproteins with immobilized fibrinogen and fibronectin using an immunoenzyme assay].
    Chulkova TM; Panasiuk AF
    Biull Eksp Biol Med; 1987 Sep; 104(9):309-11. PubMed ID: 3663917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Atherogenic modifications of low density lipoproteins during fibrin formation and fibrinolysis].
    Chulkova TM
    Vopr Med Khim; 1989; 35(2):72-5. PubMed ID: 2741416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of plasminogen activator (urokinase), plasmin, and thrombin on glycoprotein and collagenous components of basement membrane.
    Liotta LA; Goldfarb RH; Brundage R; Siegal GP; Terranova V; Garbisa S
    Cancer Res; 1981 Nov; 41(11 Pt 1):4629-36. PubMed ID: 6458354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Physico-chemical and functional characteristics of a subfraction of low-density lipoproteins isolated by ion-exchange column chromatography].
    Gorshkova IN; Medvedeva NV; Morozkin AD; Fuki IV; Gorchakova NN
    Biokhimiia; 1988 Apr; 53(4):687-93. PubMed ID: 3395647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Detection of an immunoglobulin-like serum protein possessing a high affinity for collagen].
    Zlatopol'skiĭ AD; Zykova TA; Mazurov VI
    Biokhimiia; 1983 Nov; 48(11):1897-905. PubMed ID: 6661462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The influence of platelet-smooth muscle cell interaction on the oxidative modification of low-density lipoprotein.
    Alexander JJ; Lewis I
    J Surg Res; 2002 Mar; 103(1):41-6. PubMed ID: 11855916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Interaction of gangliosides with low-density proteins from human blood].
    Timofeeva NG; Martynova MA; Pokrovskiĭ SN; Adamova IIu; Prokazova NV
    Biokhimiia; 1987 Apr; 52(4):650-4. PubMed ID: 3593794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction of heparin with low density lipoproteins. Formation of soluble high molecular weight complexes.
    Burstein M
    Biomed Pharmacother; 1982 Jan; 36(1):45-7. PubMed ID: 7126771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxidative interaction of unpaired hemoglobin chains with lipids and proteins: a key for modified serum lipoproteins in thalassemia.
    Altamentova SM; Marva E; Shaklai N
    Arch Biochem Biophys; 1997 Sep; 345(1):39-46. PubMed ID: 9281309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isolation, characterization, and functional assessment of oxidatively modified subfractions of circulating low-density lipoproteins.
    Yang CY; Raya JL; Chen HH; Chen CH; Abe Y; Pownall HJ; Taylor AA; Smith CV
    Arterioscler Thromb Vasc Biol; 2003 Jun; 23(6):1083-90. PubMed ID: 12689919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction of heparin with lipoproteins - role of the complex in the inactivation of thrombin and plasmin.
    Kecskés E; Büki KG; Bauer PI; Machovich R; Horváth I
    Thromb Haemost; 1983 Apr; 49(2):138-41. PubMed ID: 6223404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apolipoprotein B-bound lipids as a marker for evaluation of low density lipoprotein oxidation in vivo.
    Tertov VV; Kaplun VV; Dvoryantsev SN; Orekhov AN
    Biochem Biophys Res Commun; 1995 Sep; 214(2):608-13. PubMed ID: 7677772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modified low density lipoproteins differentially bind and activate the C1 complex of complement.
    Biró A; Thielens NM; Cervenák L; Prohászka Z; Füst G; Arlaud GJ
    Mol Immunol; 2007 Feb; 44(6):1169-77. PubMed ID: 16938346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Remodeling of human plasma lipoproteins by detergent perturbation.
    Pownall HJ
    Biochemistry; 2005 Jul; 44(28):9714-22. PubMed ID: 16008356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of normolipidemic very low density lipoproteins with receptors in human skin fibroblasts.
    Yamamoto M; Ranganathan S; Kottke BA
    Biochem Int; 1985 Oct; 11(4):573-81. PubMed ID: 3853463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Capture of native and in vivo modified 125I-low density lipoproteins by fibroblasts and macrophages. Effect of high density lipoproteins on this process].
    Klimov AN; Popov AV; Pleskov VM; Vinogradov AG
    Vopr Med Khim; 1985; 31(6):94-7. PubMed ID: 4090395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low density lipoprotein for oxidation and metabolic studies. Isolation from small volumes of plasma using a tabletop ultracentrifuge.
    Himber J; Bühler E; Moll D; Moser UK
    Int J Vitam Nutr Res; 1995; 65(2):137-42. PubMed ID: 7591534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection by nile red of agarose gel electrophoresed native and modified low density lipoprotein.
    Greenspan P; Gutman RL
    Electrophoresis; 1993; 14(1-2):65-8. PubMed ID: 8462517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.